Corporate Overview

Print Page Print Page        E-mail Page Email Page        RSS Feeds RSS        E-mail Alerts Email Alerts        Financial Tear Sheet Tear Sheet
Corporate ProfileAlkermes plc is a fully integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to develop innovative medicines that improve patient outcomes. The company has a diversified portfolio of more than 20 commercial drug products and a substantial clinical pipeline of product candidates that address central nervous system (CNS) disorders such as addiction, schizophrenia and depression. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and manufacturing facilities in Gainesville, Georgia and Wilmington, Ohio. For more information, please visit Alkermes’ website at www.alkermes.com.
Stock Quote
ALKS (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$44.73
Change (%) Stock is Up 0.25 (0.56%)
Volume374,852
Data as of 08/29/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote »
News Releases
DateTitle 
08/26/14Alkermes Announces Initiation of Phase 1 Clinical Study of ALKS 7106 for Treatment of PainPrinter Friendly Version
08/25/14Alkermes Submits New Drug Application to FDA for Aripiprazole Lauroxil for Treatment of SchizophreniaPrinter Friendly Version
07/31/14Alkermes plc Reports Second Quarter 2014 Financial ResultsPrinter Friendly Version

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
FirmAnalystPhone
Bank of America/Merrill LynchSteve Byrne646.855.5746
Citi ResearchJonathan Eckard212.816.1441
Cowen & Co.Ken Cacciatore646.562.1305
Credit SuisseAri Jahja212.325.0767
FBR Capital Markets & Co. William Tanner646.885.5462
Goldman Sachs & Co.Terence Flynn212.357.5057
Jefferies & Co., Inc.Biren Amin212.284.8162
JPMorgan Securities, Inc.Cory Kasimov212.622.5266
Leerink SwannMichael Schmidt617.918.4588
Mizuho SecuritiesMario Corso617.235.1742
MKM PartnersJon LeCroy203.340.5174
Morgan Stanley ResearchDavid Risinger212.761.6494
UBS Investment ResearchMarc Goodman212.713.1342

Alkermes plc is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Alkermes plc's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Alkermes plc or its management. Alkermes plc does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

For easy reference, we list below answers to many of the questions we hear most often.

1.Where is Alkermes incorporated?
2.What exchange is Alkermes stock listed on? What is Alkermes' stock symbol?
3.What is Alkermes' CUSIP #?
4.Where is Alkermes' headquarters?
5.Can I purchase shares directly from the company?
6.Who is Alkermes' transfer agent?
7.I've lost my stock certificates; how can I replace them?
8.I'm a shareholder; who should I notify of a change of address?
9.What is Alkermes' fiscal year?
1.Where is Alkermes incorporated?
 Alkermes plc is incorporated in Dublin, Ireland.

2.What exchange is Alkermes stock listed on? What is Alkermes' stock symbol?
 Alkermes is listed on the NASDAQ Stock Exchange under the ticker symbol ALKS.

3.What is Alkermes' CUSIP #?
 The CUSIP # for Alkermes' securities is G01767 105

4.Where is Alkermes' headquarters?
 Alkermes plc is headquartered in Dublin, Ireland. The company also has an R&D center in Waltham, Massachusetts and manufacturing facilities in Athlone, Ireland; Gainesville, Georgia; and Wilmington, Ohio.

5.Can I purchase shares directly from the company?
 No. Alkermes does not have a direct stock purchase plan. You may purchase shares of Alkermes through a broker.

6.Who is Alkermes' transfer agent?
 Alkermes' transfer agent is Computershare (formerly Equiserve Trust company). You can reach Computershare at:

Computershare
P.O. Box 43010
Providence, RI 02940-3010
Phone: (781) 575-2879

7.I've lost my stock certificates; how can I replace them?
 In the event that you lose your stock certificates, you should contact our transfer agent, Computershare (formerly Equiserve Trust Company). You can reach Computershare at:

Computershare
P.O. Box 43010
Providence, RI 02940-3010
Phone: (781) 575-2879

8.I'm a shareholder; who should I notify of a change of address?
 If you change your address, you should contact our transfer agent, Computershare (formerly Equiserve Trust Company). You can reach Computershare at:

Computershare
P.O. Box 43010
Providence, RI 02940-3010
Phone: (781) 575-2879

9.What is Alkermes' fiscal year?
 Alkermes' fiscal year begins January 1 and ends December 31 each year. The quarterly breakdown is as follows:

  • Q1 January 1- March 31

  • Q2 April 1 – June 30

  • Q3 July 1 - September 31

  • Q4 October 1 – December 31

  • At Alkermes, company policies and procedures provide structure for our operation and ensure that we base our decisions on our shareholders' best interests.

    Committee Charters
    Download Corporate Governance DocumentationAudit and Risk
    Download Corporate Governance DocumentationCompensation
    Download Corporate Governance DocumentationNominating and Corporate Governance
    Compliance Programs
    Download Corporate Governance DocumentationCompliance Program
    Governance Documents
    Download Corporate Governance DocumentationWhistleblower No Retaliation Policy
    Download Corporate Governance DocumentationAudit and Non-Audit Services Pre-Approval Policy
    Download Corporate Governance DocumentationLead Independent Director
    Download Corporate Governance DocumentationCorporate Governance Guidelines
    As of May 2014
    Download Corporate Governance DocumentationCode of Business Conduct and Ethics
    Download Corporate Governance DocumentationAlkermes plc Share Ownership Guidelines 2014

    Committee Composition

    Click on the above graphic to enlarge.

    NASDAQ

    Stock Quote

    ALKS (Common Stock)
    ExchangeNASDAQ (US Dollar)
    Price$44.73
    Change (%) Stock is Up 0.25 (0.56%)
    Volume374,852
    Data as of 08/29/14 4:00 p.m. ET
    Minimum 20 minute delay
    Refresh quote

    E-mail Alerts